Report copyright - HIGHLIGHTS OF PRESCRIBING INFORMATION (ibritumomab ... · Indications and Usage (1.5) 06/2018 Dosage and Administration (2.7) 06/2018 Warnings and Precautions, Embryo-Fetal Toxicity
Please pass captcha verification before submit form